Mega Genomics Limited announced on 31 March 2026 a final ordinary dividend of RMB 0.15 per share for the financial year ended 31 December 2025.

The dividend, subject to shareholder approval at the annual general meeting on 26 June 2026, will be paid in Hong Kong dollars; the exchange rate, ex-dividend date, record date, book-closure period and payment date will be disclosed in a subsequent notice. Tricor Investor Services Limited will serve as the share registrar for the distribution.

The company stated that no withholding tax applies to the declared dividend, and it has no listed warrants or convertible securities outstanding.

As at the announcement date, the board comprises three executive directors (Dr. Yu Rong, Ms. Lin Lin, Ms. Jiang Jing), one non-executive director (Ms. Guo Meiling) and three independent non-executive directors (Dr. Zhang Ying, Mr. Jia Qingfeng, Dr. Xie Dan).